Filing Details

Accession Number:
0001437749-19-011909
Form Type:
4
Zero Holdings:
No
Publication Time:
2019-06-13 06:03:42
Reporting Period:
2019-06-10
Accepted Time:
2019-06-13 06:03:42
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1389545 Novabay Pharmaceuticals Inc. NBY Pharmaceutical Preparations (2834) 680454536
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1664299 Mijia Wu Suite 6C, Building 3, Youyou Century Plz
No. 428 Yang Gao South Road
Shanghai China
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2019-06-10 47,619 $2.03 0 No 4 S Direct
Common Stock Disposition 2019-06-11 15,873 $4.04 0 No 4 S Indirect Spouse
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
No 4 S Indirect Spouse
Footnotes
  1. On May 21, 2015, Mr. Wu and his spouse each purchased a warrant, which were both subsequently exercised on September 29, 2016 for 15,873 shares of Common Stock. Mr. Wu disclosed the exercise of his warrant on October 3, 2016 but not the exercise of his spouse's warrant, which he beneficially owned. Mr. Wu's spouse subsequently sold the 15,873 shares she owned on June 11, 2019.